Prenatal and molecular diagnosis of hemophilia B.
Prenatal diagnosis was carried out on a woman who had previously given birth to a son with a spontaneous mutation of C-->T transition at nt 31133 of the factor IX (F.IX) gene. The diagnosis was performed on chorionic villi sampling by the method of amplification-created restriction site (ACRS). It revealed a female fetus with a normal F.IX gene, as confirmed by DNA sequencing after delivery. Meanwhile, a survey using the ACRS method to evaluate the inheritance of 63 individuals from 8 hemophilia B families was done. A different single-point mutation in each family was proved by DNA sequencing. One individual had a mutation with a naturally-created restriction site. In each of the remaining patients, we were able to show an enzyme-cutting site in their DNA amplification product for ACRS with the designed mutagenesis primers. All patients and carriers could be diagnosed accurately by comparing ACRS results with clinical and laboratory findings. There were new novel mutations among the patients.
Young
J H
JH
Department of Internal Medicine, Taichung Veterans General Hospital, Taiwan.
Wang
J C
JC
Gau
J P
JP
Hu
H T
HT
D001483:Base Sequence; D015193:Chorionic Villi Sampling; D004247:DNA / Q000737:chemistry; D017931:DNA Primers; D005164:Factor IX / Q000235:genetics*; D005260:Female; D002836:Hemophilia B / Q000175:diagnosis* / Q000235:genetics*; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D016296:Mutagenesis; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D017422:Sequence Analysis, DNA
D017931:DNA Primers; D005164:Factor IX; D004247:DNA